Health and Fitness

Experimental Nasal Influenza Vaccine Tested in Kids, Teens

NIH-supported Phase 1 trial of potential broadly protective vaccine.
Bethesda, Maryland—(ENEWSPF)—September 18, 2018
Contact: Anne A. Oplinger
An early-stage clinical trial testing the safety and immune-stimulating ability of an experimental nasal influenza vaccine in healthy 9- to 17-year-old children and teens has begun enrolling participants at a Vaccine and Treatment Evaluation Unit (VTEU) site at Saint Louis University, Missouri. The VTEU is funded by the National Institute of Allergy and Infectious Diseases . . .

First Trustee Forum

First Mayoral Forum

Please follow & like us :)